Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Home-based Rehabilitation Program to Counter the Motor Impairments and Activity Limitations Experienced by People With Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay

NCT05768750 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT05768750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05768750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Home-based Rehabilitation Program to Counter the Motor Impairments and Activity Limitations Experienced by People With Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
Lead sponsor
Université de Sherbrooke
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2022
Completion date
December 1, 2024
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal recessive spastic ataxia of charlevoix-saguenay